CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair
Titel:
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair
Auteur:
Shenoy, T.R. Boysen, G. Wang, M.Y. Xu, Q.Z. Guo, W. Koh, F.M. Wang, C. Zhang, L.Z. Wang, Y. Gil, V. Aziz, S. Christova, R. Rodrigues, D.N. Crespo, M. Rescigno, P. Tunariu, N. Riisnaes, R. Zafeiriou, Z. Flohr, P. Yuan, W. Knight, E. Swain, A. Ramalho-Santos, M. Xu, D.Y. de Bono, J. Wu, H.